Описание
Quantification of gut permeability markers or short-chain fatty acid concentrations in fecal samples from experimental groups. Butyrate, propionate, and acetate levels are compared to assess the metabolic impact of Ginkgo biloba on the gut environment.
More Figures from This Paper
Figure 6
Alpha diversity analysis of gut microbiota in Alzheimer's model mice treated with Ginkgo biloba extract. Shannon and Simpson diversity indices indicate shifts in microbial community richness and evenness following treatment.
chart
Figure 7
Beta diversity analysis using principal coordinate plots to compare gut microbial community structures across treatment groups. Distinct clustering patterns suggest Ginkgo biloba extract alters the overall composition of the gut microbiome in Alzheimer's model mice.
chart
Figure 8
Taxonomic composition of gut microbiota at the phylum level across experimental groups. Relative abundance of Firmicutes, Bacteroidetes, and other phyla is compared between Ginkgo biloba-treated and control Alzheimer's model mice.
chart
Figure 9
Genus-level taxonomic analysis of gut flora showing differential abundance of specific bacterial genera in response to Ginkgo biloba extract treatment. Several genera associated with short-chain fatty acid production appear enriched in the treatment group.
chart
Figure 10
LEfSe analysis identifying microbial biomarkers that distinguish Ginkgo biloba-treated mice from controls. Discriminant taxa are ranked by effect size, revealing key bacterial groups responsive to treatment.
chart
Figure 11
Cladogram visualization of microbial taxa significantly associated with Ginkgo biloba extract treatment. Hierarchical taxonomic relationships from phylum to genus level highlight lineages that are differentially abundant between groups.
diagramFigure 23
ChartSource Paper
Ginkgo biloba Extract Drives Gut Flora and Microbial Metabolism Variation in a Mouse Model of Alzheimer's Disease.Cite This Figure
 > Source: Ting Yu et al. "Ginkgo biloba Extract Drives Gut Flora and Microbial Metabolism Variation in a M." *Pharmaceutics*, 2023. PMID: [38140087](https://pubmed.ncbi.nlm.nih.gov/38140087/)
<figure> <img src="https://pdfs.citedhealth.com/figures/38140087/189.png" alt="Quantification of gut permeability markers or short-chain fatty acid concentrations in fecal samples from experimental groups. Butyrate, propionate, and acetate levels are compared to assess the metabolic impact of Ginkgo biloba on the gut environment." /> <figcaption>Figure 23. Quantification of gut permeability markers or short-chain fatty acid concentrations in fecal samples from experimental groups. Butyrate, propionate, and acetate levels are compared to assess the metabolic impact of Ginkgo biloba on the gut environment.<br> Source: Ting Yu et al. "Ginkgo biloba Extract Drives Gut Flora and Microbial Metabolism Variation in a M." <em>Pharmaceutics</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38140087/">38140087</a></figcaption> </figure>